Mark Andrew White

Insider Reports History

Entity
Individual
Location
C/O Rocket Pharmaceuticals, Inc., 9 Cedarbrook Drive, Cranbury, NJ
Signature
/s/ Martin Wilson, as attorney-in-fact for Mark Andrew White
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Andrew White:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ROCKET PHARMACEUTICALS, INC. General Manager, Commercial Affairs Common Stock 69.1K $1.15M $16.63 Oct 31, 2024 Direct
ROCKET PHARMACEUTICALS, INC. General Manager, Commercial Affairs Stock Option (Right to Buy) 32.7K $411K $12.55 Feb 16, 2024 Direct

Insider Reports Filed by Mark Andrew White

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RCKT ROCKET PHARMACEUTICALS, INC. Oct 31, 2024 1 -$51.2K 4 Nov 4, 2024 General Manager, Commercial Affairs
RCKT ROCKET PHARMACEUTICALS, INC. Jul 8, 2024 1 -$61.7K 4 Jul 9, 2024 General Manager, Commercial Affairs
RCKT ROCKET PHARMACEUTICALS, INC. Apr 8, 2024 1 -$309K 4 Apr 10, 2024 General Manager, Commercial Affairs
RCKT ROCKET PHARMACEUTICALS, INC. Feb 16, 2024 2 $0 4 Feb 21, 2024 Chief Medical Officer
RCKT ROCKET PHARMACEUTICALS, INC. Apr 4, 2023 2 $0 4 Apr 12, 2023 Chief Medical Officer
RCKT ROCKET PHARMACEUTICALS, INC. Apr 4, 2023 0 $0 3 Apr 12, 2023 Chief Medical Officer